KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Cash & Equivalents (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -6.22%
Dec 31, 2025 -35.08%
Sep 30, 2025 24.82%
Jun 30, 2025 15.85%
Mar 31, 2025 5.11%
Dec 31, 2024 31.13%
Sep 30, 2024 25.38%
Jun 30, 2024 -32.55%
Mar 31, 2024 -18.61%
Dec 31, 2023 52.57%
Sep 30, 2023 -10.25%
Jun 30, 2023 -6.93%
Mar 31, 2023 -1.40%
Dec 31, 2022 17.96%
Sep 30, 2022 -28.06%
Jun 30, 2022 -13.09%
Mar 31, 2022 -11.52%
Dec 31, 2021 3.24%
Sep 30, 2021 22.82%
Jun 30, 2021 0.38%
Mar 31, 2021 -24.50%
Dec 31, 2020 -25.16%
Sep 30, 2020 -2.50%
Jun 30, 2020 26.03%
Mar 31, 2020 28.11%
Dec 31, 2019 -59.51%
Sep 30, 2019 7.34%
Jun 30, 2019 287.24%
Mar 31, 2019 6.14%
Dec 31, 2018 27.79%
Sep 30, 2018 8.18%
Jun 30, 2018 -6.42%
Mar 31, 2018 -1.46%
Dec 31, 2017 16.73%
Sep 30, 2017 33.83%
Jun 30, 2017 -11.25%
Mar 31, 2017 -7.72%
Dec 31, 2016 23.46%
Sep 30, 2016 16.97%
Jun 30, 2016 10.97%
Mar 31, 2016 10.86%
Dec 31, 2015 -40.00%
Sep 30, 2015 -5.33%
Jun 30, 2015 -33.29%
Mar 31, 2015 12.98%
Dec 31, 2014 14.84%
Sep 30, 2014 13.29%
Jun 30, 2014 -18.05%
Mar 31, 2014 45.71%
Dec 31, 2013 102.48%
Sep 30, 2013 -2.75%
Jun 30, 2013 34.39%
Mar 31, 2013 -18.18%
Dec 31, 2012 10.18%
Sep 30, 2012 -46.34%
Jun 30, 2012 21.41%
Mar 31, 2012 -60.06%
Dec 31, 2011 29.19%
Sep 30, 2011 21.99%
Jun 30, 2011 7.64%
Mar 31, 2011 -32.35%
Dec 31, 2010 -33.61%
Sep 30, 2010 28.10%
Jun 30, 2010 15.25%
Mar 31, 2010 -33.16%
Dec 31, 2009 20.67%
Sep 30, 2009 -15.19%